STAT4 (Q14765) variants and mutations
STAT4 (also known as Q14765) is a human protein-coding gene encoding a signal transducer and activator of transcription 4 protein. It transduces signals from IL-12 and related cytokines to promote Th1 differentiation and IFN-gamma production. Common variants strongly influence susceptibility to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. This analysis covers 1,017 STAT4 variants and mutations. Of these, 89% have computational variant effect predictions. Disease context includes disabling pansclerotic morphea of childhood, rheumatoid arthritis, and systemic lupus erythematosus. Example STAT4 variants include S2A, Q3E, and N5S.
Variant analysis overview
- Gene: STAT4
- Protein: Q14765
- UniProt accession: Q14765
- Organism: Homo sapiens
- Variants analyzed: 1017
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 835 unspecified-consequence records; 74 missense variants; 87 synonymous variants; 7 splice-region variants; 8 stop-gained variants; 2 in-frame deletions; 4 frameshift variants
- Prediction scores: 906 variants have prediction scores (89% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: disabling pansclerotic morphea of childhood, rheumatoid arthritis, systemic lupus erythematosus, hypothyroidism, ACPA-positive rheumatoid arthritis, systemic sclerosis, myxedema, thyroid gland disorder, primary biliary cholangitis, autoimmune disease, Behcet disease, Oral ulcer.
Protein structure and variant hotspots
- Protein features: 1 domains; 3 post-translational modification sites.
- Structural context: 170 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable STAT4 variants
Examples include S2A, Q3E, N5S, Q6*, V7A, V7I, V7S, Q9*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2A (p.Ser2Ala), rs906280014, ClinGen CA62986893, cosmic curated COSV10467, ClinVar RCV002781485, REVEL 0.23, MetaLR 0.11, Uncertain significance, not specified; not provided
- Q3E (p.Gln3Glu), cosmic curated COSV61832
- N5S (p.Asn5Ser), rs2471013897, ClinGen CA350003000, ClinVar RCV003553362, REVEL 0.08, MetaLR 0.08, Uncertain significance, not provided
- Q6* (p.Gln6Ter), cosmic curated COSV61831
- V7A (p.Val7Ala), ExAC rs778760914, gnomAD rs778760914, REVEL 0.40, MetaLR 0.15
- V7I (p.Val7Ile), Ensembl rs1699504520, REVEL 0.12, MetaLR 0.08, Uncertain significance, not specified
- V7S (p.Val7Ser), NCI-TCGA Cosmic COSV6182, MetaLR 0.27, MetaSVM -0.54, Variant assessed as somatic; high impact.
- Q9* (p.Gln9Ter), cosmic curated COSV61831
- Q9H (p.Gln9His), gnomAD rs1363166746, REVEL 0.29, MetaLR 0.25
- K13T (p.Lys13Thr), cosmic curated COSV10610, MetaLR 0.09, MetaSVM -0.92
- L15W (p.Leu15Trp), NCI-TCGA TCGA novel, MetaLR 0.43, MetaSVM -0.07, Variant assessed as somatic; moderate impact.
- Q17* (p.Gln17Ter), gnomAD rs1699504085, CADD 37.00
- V18E (p.Val18Glu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Variant assessed as somatic; moderate impact.
- F21L (p.Phe21Leu), rs1418758324, ClinGen CA350002877, ClinVar RCV003704971, TOPMed rs1418758324, REVEL 0.09, MetaLR 0.02, Uncertain significance, not provided
- Y22C (p.Tyr22Cys), Ensembl rs934903650, MetaLR 0.68, MetaSVM 0.51
- D23N (p.Asp23Asn), cosmic curated COSV10743, MetaLR 0.22, MetaSVM -0.70
- D24V (p.Asp24Val), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, MetaLR 0.32, MetaSVM -0.42, Variant assessed as somatic; moderate impact.
- N25S (p.Asn25Ser), gnomAD rs1184514035, REVEL 0.09, MetaLR 0.05
- P27L (p.Pro27Leu), NCI-TCGA TCGA novel, MetaLR 0.69, MetaSVM 0.47, Variant assessed as somatic; moderate impact.
- M28I (p.Met28Ile), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, MetaLR 0.26, MetaSVM -0.59, Variant assessed as somatic; moderate impact.
- E29D (p.Glu29Asp), cosmic curated COSV10743
- E29K (p.Glu29Lys), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Variant assessed as somatic; moderate impact.
- R31Q (p.Arg31Gln), gnomAD rs867270496, MetaLR 0.77, MetaSVM 0.67
- R31W (p.Arg31Trp), NCI-TCGA Cosmic COSV6182, cosmic curated COSV61828, REVEL 0.81, MetaLR 0.77, Variant assessed as somatic; moderate impact.
- H32I (p.His32Ile), NCI-TCGA TCGA novel, MetaLR 0.15, MetaSVM -0.87, Variant assessed as somatic; high impact.
- H32Q (p.His32Gln), rs766134008, ClinGen CA2031000, ClinVar RCV003032011, ExAC rs766134008, REVEL 0.11, MetaLR 0.03, Uncertain significance, not provided
- Q36H (p.Gln36His), cosmic curated COSV10063
- I38L (p.Ile38Leu), gnomAD rs1294017171, REVEL 0.22, MetaLR 0.20
- I38M (p.Ile38Met), cosmic curated COSV10063
- I38T (p.Ile38Thr), rs2471013651, ClinGen CA350002755, ClinVar RCV002592869, Uncertain significance, not provided
- E39D (p.Glu39Asp), NCI-TCGA Cosmic COSV6182, cosmic curated COSV61828, MetaLR 0.73, MetaSVM 0.58, Variant assessed as somatic; moderate impact.
- Q41E (p.Gln41Glu), gnomAD rs1207353579, REVEL 0.46, MetaLR 0.40
- D42G (p.Asp42Gly), ExAC rs761161672, TOPMed rs761161672, gnomAD rs761161672, REVEL 0.72, MetaLR 0.32, Uncertain significance, not provided
- W43* (p.Trp43Ter), cosmic curated COSV10606, CADD 38.00
- W43R (p.Trp43Arg), cosmic curated COSV61830, gnomAD rs1699503036, REVEL 0.89, MetaLR 0.71
- E44G (p.Glu44Gly), cosmic curated COSV61829, Ensembl rs868421245, REVEL 0.26, MetaLR 0.16
- E44K (p.Glu44Lys), cosmic curated COSV10526, REVEL 0.16, MetaLR 0.17
- A45T (p.Ala45Thr), rs2471010215, ClinGen CA350002693, ClinVar RCV002638886, REVEL 0.05, MetaLR 0.05, Uncertain significance, not provided
- A46S (p.Ala46Ser), rs2471010207, ClinGen CA350002685, ClinVar RCV002933561, REVEL 0.35, MetaLR 0.32, Uncertain significance, not provided
- A46V (p.Ala46Val), rs1003116465, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Ensembl rs1003116465, REVEL 0.25, MetaLR 0.26, Uncertain significance, not provided
- S47A (p.Ser47Ala), TOPMed rs1381422972, gnomAD rs1381422972, REVEL 0.09, MetaLR 0.04, Uncertain significance, not specified
- N48T (p.Asn48Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N48Y (p.Asn48Tyr), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Variant assessed as somatic; moderate impact.
- N49S (p.Asn49Ser), TOPMed rs1277833779, gnomAD rs1277833779, REVEL 0.10, MetaLR 0.09
- T51A (p.Thr51Ala), NCI-TCGA TCGA novel, TOPMed rs1699471158, REVEL 0.12, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- T51I (p.Thr51Ile), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, NCI-TCGA Cosmic COSV6182, Variant assessed as somatic; moderate impact.
- T51S (p.Thr51Ser), cosmic curated COSV61828, MetaLR 0.03, MetaSVM -0.91
- M52I (p.Met52Ile), cosmic curated COSV10969, REVEL 0.09, MetaLR 0.14
- M52T (p.Met52Thr), TOPMed rs1338661647, gnomAD rs1338661647, REVEL 0.17, MetaLR 0.13
- A53T (p.Ala53Thr), cosmic curated COSV61832, Ensembl rs1699470824
- A53V (p.Ala53Val), rs1308664127, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, gnomAD rs1308664127, REVEL 0.47, MetaLR 0.41, Variant assessed as somatic; moderate impact.
- T54A (p.Thr54Ala), rs1699470596, ClinGen CA350002630, ClinVar RCV003723734, Ensembl rs1699470596, REVEL 0.17, MetaLR 0.10, Uncertain significance, not provided
- T54M (p.Thr54Met), rs750095435, ClinGen CA2030975, NCI-TCGA Cosmic COSV6183, cosmic curated COSV61832, REVEL 0.20, MetaLR 0.14, Conflicting interpretations, not provided; not specified
- I55S (p.Ile55Ser), rs2125459825, ClinGen CA350002621, ClinVar RCV001871314, Ensembl rs2125459825, AlphaMissense 0.39, MetaLR 0.14, Uncertain significance, not provided
- L56F (p.Leu56Phe), gnomAD rs1320919269, REVEL 0.29, MetaLR 0.32
- L57F (p.Leu57Phe), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, REVEL 0.12, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- Q58E (p.Gln58Glu), gnomAD rs1284825965, REVEL 0.15, MetaLR 0.09
- Q58R (p.Gln58Arg), rs990725052, ClinGen CA62986760, ClinVar RCV001983436, TOPMed rs990725052, REVEL 0.15, MetaLR 0.10, Uncertain significance, not provided
- I62M (p.Ile62Met), TOPMed rs1699469607, MetaLR 0.08, MetaSVM -0.97
- E66K (p.Glu66Lys), cosmic curated COSV10526
- Q67L (p.Gln67Leu), gnomAD rs1444276228, REVEL 0.34, MetaLR 0.19, Uncertain significance, not provided
- G69D (p.Gly69Asp), Ensembl rs1699468986
- G69V (p.Gly69Val), NCI-TCGA Cosmic COSV6182, cosmic curated COSV61828, MetaLR 0.14, MetaSVM -0.90, Variant assessed as somatic; moderate impact.
- R70C (p.Arg70Cys), rs1468059700, NCI-TCGA Cosmic COSV6182, cosmic curated COSV61828, gnomAD rs1468059700, REVEL 0.39, MetaLR 0.32, Variant assessed as somatic; moderate impact.
- R70H (p.Arg70His), rs751076320, NCI-TCGA Cosmic COSV6182, cosmic curated COSV61828, ExAC rs751076320, REVEL 0.30, MetaLR 0.22, Uncertain significance, not provided
- R70L (p.Arg70Leu), rs751076320, ClinGen CA2030971, ClinVar RCV002580579, ClinVar RCV006327470, REVEL 0.32, MetaLR 0.27, Uncertain significance, not provided; not specified
- S72F (p.Ser72Phe), rs267599129, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, TOPMed rs267599129, AlphaMissense 0.18, MetaLR 0.26, Variant assessed as somatic; moderate impact.
- S72Y (p.Ser72Tyr), TOPMed rs267599129, REVEL 0.30, AlphaMissense 0.18
- K73E (p.Lys73Glu), ExAC rs763673195, gnomAD rs763673195, REVEL 0.12, MetaLR 0.07
- E74K (p.Glu74Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K75E (p.Lys75Glu), cosmic curated COSV61830, REVEL 0.15, MetaLR 0.07
- L79F (p.Leu79Phe), rs1405872272, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, TOPMed rs1405872272, REVEL 0.33, MetaLR 0.32, Variant assessed as somatic; moderate impact.
- L79S (p.Leu79Ser), Ensembl rs1699468113, REVEL 0.28, MetaLR 0.32
- I80M (p.Ile80Met), TOPMed rs957846209, REVEL 0.13, MetaLR 0.07
- H81Q (p.His81Gln), cosmic curated COSV10651, MetaLR 0.39, MetaSVM -0.24
- N82I (p.Asn82Ile), cosmic curated COSV61827, MetaLR 0.35, MetaSVM -0.31
- N82S (p.Asn82Ser), ExAC rs777271668, gnomAD rs777271668, REVEL 0.34, MetaLR 0.27
- K84N (p.Lys84Asn), cosmic curated COSV99061
- K84R (p.Lys84Arg), cosmic curated COSV61830, MetaLR 0.12, MetaSVM -0.88
- R85K (p.Arg85Lys), gnomAD rs1202108588, MetaLR 0.11, MetaSVM -0.98
- I86L (p.Ile86Leu), gnomAD rs1462946559, REVEL 0.21, MetaLR 0.15
- R87K (p.Arg87Lys), rs202184860, ClinGen CA2030966, ClinVar RCV001988114, ClinVar RCV004043802, REVEL 0.08, MetaLR 0.03, Uncertain significance, not specified; not provided
- R87M (p.Arg87Met), NCI-TCGA Cosmic COSV6182, cosmic curated COSV61828, REVEL 0.24, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- K88N (p.Lys88Asn), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, REVEL 0.06, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- V89I (p.Val89Ile), TOPMed rs1699467071
- L90F (p.Leu90Phe), NCI-TCGA Cosmic COSV6183, cosmic curated COSV61830, gnomAD rs1699466959, REVEL 0.35, MetaLR 0.26, Variant assessed as somatic; moderate impact.
- Q91* (p.Gln91Ter), cosmic curated COSV61832, CADD 37.00
- Q91=, NCI-TCGA Cosmic COSV1006, Variant assessed as somatic; low impact.
- Q91K (p.Gln91Lys), cosmic curated COSV10063, REVEL 0.32, MetaLR 0.21
- Q91L (p.Gln91Leu), cosmic curated COSV10818, MetaLR 0.15, MetaSVM -0.77
- Q91R (p.Gln91Arg), rs773503051, ClinGen CA2030965, ClinVar RCV001985632, ExAC rs773503051, REVEL 0.30, MetaLR 0.23, Uncertain significance, not provided
- G92E (p.Gly92Glu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Variant assessed as somatic; moderate impact.
- F94S (p.Phe94Ser), cosmic curated COSV61828, MetaLR 0.12, MetaSVM -0.96
- H95N (p.His95Asn), NCI-TCGA Cosmic COSV6182, ExAC rs757999757, gnomAD rs757999757, MetaLR 0.03, MetaSVM -0.99, Variant assessed as somatic; moderate impact.
- H95R (p.His95Arg), TOPMed rs1322131618, gnomAD rs1322131618, REVEL 0.14, MetaLR 0.07
- H95Y (p.His95Tyr), rs757999757, NCI-TCGA Cosmic COSV6182, cosmic curated COSV61829, ExAC rs757999757, REVEL 0.12, MetaLR 0.11, Variant assessed as somatic; moderate impact.
- G96E (p.Gly96Glu), NCI-TCGA Cosmic COSV6182, cosmic curated COSV61829, Variant assessed as somatic; moderate impact.
- N97K (p.Asn97Lys), rs1559055945, ClinGen CA349920596, ClinVar RCV003556887, Ensembl rs1559055945, AlphaMissense 0.42, MetaLR 0.14, Uncertain significance, not provided
- P98L (p.Pro98Leu), cosmic curated COSV10818, MetaLR 0.64, MetaSVM 0.36
- P98S (p.Pro98Ser), cosmic curated COSV10467, REVEL 0.79, MetaLR 0.61
- P98T (p.Pro98Thr), cosmic curated COSV10063, REVEL 0.81, MetaLR 0.64
- M99T (p.Met99Thr), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, MetaLR 0.05, MetaSVM -1.08, Variant assessed as somatic; moderate impact.
- M99V (p.Met99Val), ExAC rs752105122, gnomAD rs752105122, REVEL 0.14, MetaLR 0.05
- H100L (p.His100Leu), gnomAD rs1267779076, REVEL 0.31, MetaLR 0.07, Uncertain significance
- H100N (p.His100Asn), cosmic curated COSV10526
- H100Q (p.His100Gln), TOPMed rs1697317350, MetaLR 0.11, MetaSVM -1.03
- H100R (p.His100Arg), rs1267779076, ClinGen CA349920576, ClinVar RCV002583913, gnomAD rs1267779076, REVEL 0.16, MetaLR 0.07, Uncertain significance, not provided
- V101A (p.Val101Ala), rs778453112, ClinGen CA2030925, ClinVar RCV001938583, ClinVar RCV006327349, REVEL 0.31, MetaLR 0.10, Uncertain significance, not provided; not specified
- V101I (p.Val101Ile), gnomAD rs1196585329, REVEL 0.08, MetaLR 0.04, Uncertain significance, not provided
- A102V (p.Ala102Val), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, MetaLR 0.26, MetaSVM -0.62, Variant assessed as somatic; moderate impact.
- V103A (p.Val103Ala), cosmic curated COSV61827, MetaLR 0.05, MetaSVM -1.04
- V104F (p.Val104Phe), ExAC rs756625612, gnomAD rs756625612, REVEL 0.27, MetaLR 0.21, Uncertain significance, not specified
- V104I (p.Val104Ile), ExAC rs756625612, gnomAD rs756625612, REVEL 0.08, MetaLR 0.05
- N107D (p.Asn107Asp), rs1337434431, ClinGen CA349920536, ClinVar RCV003702880, AlphaMissense 0.09, MetaLR 0.19, Uncertain significance, not provided
- N107H (p.Asn107His), rs1337434431, NCI-TCGA Cosmic COSV6182, cosmic curated COSV61829, gnomAD rs1337434431, REVEL 0.20, AlphaMissense 0.09, Variant assessed as somatic; moderate impact.
- N107Y (p.Asn107Tyr), gnomAD rs1337434431, REVEL 0.30, AlphaMissense 0.09
- C108S (p.Cys108Ser), rs1697316431, ClinGen CA349920525, ClinVar RCV002613609, Ensembl rs1697316431, REVEL 0.46, MetaLR 0.33, Uncertain significance, not provided
- R110K (p.Arg110Lys), TOPMed rs1287831571, gnomAD rs1287831571, REVEL 0.14, MetaLR 0.09
- E112* (p.Glu112Ter), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, NCI-TCGA Cosmic COSV6183, Variant assessed as somatic; high impact., in a breast cancer sample
- E112Q (p.Glu112Gln), cosmic curated COSV61832, UniProt VAR 036002, Uncertain significance, in a breast cancer sample
- E112V (p.Glu112Val), NCI-TCGA TCGA novel, MetaLR 0.68, MetaSVM 0.51, Variant assessed as somatic; moderate impact., in a breast cancer sample
- I115T (p.Ile115Thr), NCI-TCGA Cosmic COSV6183, cosmic curated COSV61830, MetaLR 0.36, MetaSVM -0.24, Variant assessed as somatic; moderate impact.
- I115V (p.Ile115Val), rs3024839, ClinGen CA2030920, ClinVar RCV000917583, UniProt VAR 020190, REVEL 0.18, MetaLR 0.17, Likely benign, not provided
- A117V (p.Ala117Val), rs2125268711, ClinGen CA349920420, ClinVar RCV001920157, Ensembl rs2125268711, AlphaMissense 0.24, MetaLR 0.19, Uncertain significance, not provided
- A118T (p.Ala118Thr), rs372012413, ClinGen CA2030919, ClinVar RCV001891935, ESP rs372012413, REVEL 0.06, MetaLR 0.04, Uncertain significance, not provided
- A119D (p.Ala119Asp), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, REVEL 0.42, MetaLR 0.40, Variant assessed as somatic; moderate impact.
- N120D (p.Asn120Asp), rs763055396, ClinGen CA2030918, ClinVar RCV002605053, ExAC rs763055396, REVEL 0.05, MetaLR 0.08, Uncertain significance, not provided
- N120S (p.Asn120Ser), gnomAD rs1355355814, REVEL 0.09, MetaLR 0.04
- V123F (p.Val123Phe), rs1697314886, ClinGen CA349920352, ClinVar RCV003695450, Ensembl rs1697314886, AlphaMissense 0.13, MetaLR 0.42, Uncertain significance, not provided
- G125E (p.Gly125Glu), ExAC rs773188982, gnomAD rs773188982, REVEL 0.49, MetaLR 0.73
- G125R (p.Gly125Arg), TOPMed rs1451770735, gnomAD rs1451770735, REVEL 0.54, MetaLR 0.80
- G125W (p.Gly125Trp), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Variant assessed as somatic; moderate impact.
- P126S (p.Pro126Ser), rs1305163633, Ensembl rs1305163633, AlphaMissense 0.18, MetaLR 0.75, Variant assessed as somatic; moderate impact.
- L127P (p.Leu127Pro), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, Variant assessed as somatic; moderate impact.
- E128V (p.Glu128Val), rs140675301, ClinGen CA2030889, ClinVar RCV001326416, ClinVar RCV003938632, REVEL 0.59, MetaLR 0.64, Conflicting interpretations, not provided
- S130A (p.Ser130Ala), TOPMed rs1697214931
- S130F (p.Ser130Phe), cosmic curated COSV61829, MetaLR 0.79, MetaSVM 0.59
- Q132R (p.Gln132Arg), TOPMed rs1286913686, gnomAD rs1286913686, REVEL 0.59, MetaLR 0.74
- S134F (p.Ser134Phe), NCI-TCGA TCGA novel, MetaLR 0.61, MetaSVM 0.29, Variant assessed as somatic; moderate impact.
- S135* (p.Ser135Ter), NCI-TCGA Cosmic COSV1006, NCI-TCGA Cosmic COSV1044, cosmic curated COSV10442, Variant assessed as somatic; high impact.
- S135A (p.Ser135Ala), cosmic curated COSV61829
- S135L (p.Ser135Leu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, NCI-TCGA Cosmic COSV1044, MetaLR 0.32, MetaSVM -0.60, Variant assessed as somatic; moderate impact.
- S137L (p.Ser137Leu), cosmic curated COSV10743, NCI-TCGA TCGA novel, MetaLR 0.20, MetaSVM -0.86, Variant assessed as somatic; moderate impact.
- E138A (p.Glu138Ala), Ensembl rs1697214448, REVEL 0.32, MetaLR 0.41
- R141K (p.Arg141Lys), cosmic curated COSV61829, 1000Genomes rs899829959, TOPMed rs899829959, gnomAD rs899829959, REVEL 0.13, MetaLR 0.07, Uncertain significance, not provided
- R141S (p.Arg141Ser), NCI-TCGA TCGA novel, REVEL 0.23, MetaLR 0.17, Variant assessed as somatic; moderate impact.
- R141T (p.Arg141Thr), 1000Genomes rs899829959, TOPMed rs899829959, gnomAD rs899829959, MetaLR 0.25, MetaSVM -0.59
- V143G (p.Val143Gly), rs866566754, ClinGen CA62697546, ClinVar RCV001926923, Ensembl rs866566754, REVEL 0.39, MetaLR 0.14, Uncertain significance, not provided
- V143L (p.Val143Leu), ESP rs370819441, ExAC rs370819441, TOPMed rs370819441, gnomAD rs370819441, REVEL 0.11, MetaLR 0.04, Uncertain significance
- V143M (p.Val143Met), rs370819441, ClinGen CA2030886, ClinVar RCV003086031, ESP rs370819441, REVEL 0.07, MetaLR 0.07, Uncertain significance, not provided
- E144* (p.Glu144Ter), cosmic curated COSV10610, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E144D (p.Glu144Asp), ExAC rs757804856, TOPMed rs757804856, gnomAD rs757804856, MetaLR 0.32, MetaSVM -0.44, Uncertain significance, not provided
- H145Q (p.His145Gln), Ensembl rs1574130044
- H145Y (p.His145Tyr), NCI-TCGA Cosmic COSV6183, cosmic curated COSV61830, Variant assessed as somatic; moderate impact.
- K146Q (p.Lys146Gln), rs2470798342, ClinGen CA349919547, ClinVar RCV004465510, REVEL 0.30, MetaLR 0.23, Uncertain significance, not specified
- K146R (p.Lys146Arg), gnomAD rs1449256873, REVEL 0.10, MetaLR 0.11
- V147A (p.Val147Ala), cosmic curated COSV10743, MetaLR 0.27, MetaSVM -0.59
- V147G (p.Val147Gly), gnomAD rs1340651373, REVEL 0.62, MetaLR 0.35
- A148P (p.Ala148Pro), ExAC rs747495835, gnomAD rs747495835, REVEL 0.28, MetaLR 0.16
- A148T (p.Ala148Thr), rs747495835, ClinGen CA349919533, ClinVar RCV003440113, REVEL 0.06, MetaLR 0.09, Uncertain significance, not provided
- A148V (p.Ala148Val), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, MetaLR 0.20, MetaSVM -0.91, Variant assessed as somatic; moderate impact.
- A149G (p.Ala149Gly), ExAC rs778170459, TOPMed rs778170459, gnomAD rs778170459, REVEL 0.15, MetaLR 0.16
- A149V (p.Ala149Val), cosmic curated COSV61832, ExAC rs778170459, TOPMed rs778170459, gnomAD rs778170459, REVEL 0.10, MetaLR 0.14
- I150F (p.Ile150Phe), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10063, NCI-TCGA Cosmic COSV6182, Variant assessed as somatic; moderate impact.
- I150T (p.Ile150Thr), cosmic curated COSV10591, MetaLR 0.21, MetaSVM -0.64
- I150V (p.Ile150Val), NCI-TCGA Cosmic COSV1006, NCI-TCGA Cosmic COSV6182, cosmic curated COSV61829, Ensembl rs1697213354, REVEL 0.21, MetaLR 0.18, Variant assessed as somatic; moderate impact.
- K151R (p.Lys151Arg), NCI-TCGA Cosmic COSV6183, cosmic curated COSV61831, MetaLR 0.21, MetaSVM -0.70, Variant assessed as somatic; moderate impact.
- N152D (p.Asn152Asp), cosmic curated COSV10743
- N152H (p.Asn152His), NCI-TCGA Cosmic COSV6182, NCI-TCGA Cosmic COSV6183, cosmic curated COSV61832, Variant assessed as somatic; moderate impact.
- N152K (p.Asn152Lys), gnomAD rs938231505, REVEL 0.12, MetaLR 0.15
- N152Y (p.Asn152Tyr), cosmic curated COSV61829
- S153N (p.Ser153Asn), cosmic curated COSV10818, Ensembl rs1574130004
- S153T (p.Ser153Thr), cosmic curated COSV10526, MetaLR 0.20, MetaSVM -0.85
- V154M (p.Val154Met), ExAC rs758720903, gnomAD rs758720903, REVEL 0.23, MetaLR 0.31
- Q155K (p.Gln155Lys), TOPMed rs887698929, gnomAD rs887698929, REVEL 0.35, MetaLR 0.45
- M156T (p.Met156Thr), ESP rs376677137, ExAC rs376677137, TOPMed rs376677137, gnomAD rs376677137, REVEL 0.10, MetaLR 0.18
- M156V (p.Met156Val), Ensembl rs906967754, REVEL 0.03, MetaLR 0.11
- T157A (p.Thr157Ala), rs372399682, ClinGen CA62695630, cosmic curated COSV10888, ClinVar RCV003719629, REVEL 0.12, MetaLR 0.14, Uncertain significance, not provided; not specified
- T157R (p.Thr157Arg), rs2470788035, ClinGen CA349918902, ClinVar RCV003542128, Uncertain significance, not provided
- E158K (p.Glu158Lys), cosmic curated COSV61828, REVEL 0.23, MetaLR 0.26
Public STAT4 analysis runs
- STAT4 analysis run — STAT4 (1,017 variants) — completed 2026-08-19